Analysis of COVID-19 cases and identification of risk groups in Estonia

Grant number: RITA1/02-120

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $627,997
  • Funder

    Estonian Research Council
  • Principal Investigator

    Uusküla, Anneli
  • Research Location

    Estonia
  • Lead Research Institution

    University of Tartu
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease susceptibility

  • Special Interest Tags

    Data Management and Data Sharing

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The whole world is facing an existential health crisis: a novel disease, COVID-19, caused by the coronavirus SARS-CoV-2. Health systems have no previous experience in the treatment and prevention of disease/long-term consequences. The aim of the study is a systematic analysis of SARS-Cov-2 morbidity, disease severity, immune response and health consequences of infection in Estonia, which enables informed decisions in future outbreaks and develops the use of health data for medical decision support, public health monitoring, health planning and interventions effectiveness analysis. The study team includes physicians, epidemiologists, public health researchers, virologists, and computer scientists. Our project benefits from the ties to the international COVID-19 research community. Bringing Estonian data to a standard format (OMOP), ensures fast local analysis capabilities and allows developing analysis protocols and prediction models prepared by other research groups on Estonian data.